- We think that after some consolidation of recent strong gains, shares of Fulgent Genetics have further upside.
- The market for genetic testing is still in the early innings, and the company has established itself as a genuine supplier.
- The company is on the verge of becoming profitable, and the shares are still not that expensive, despite an 80%+ rise this year.
Fulgent Genetics Has Further Upside
April 14th, 2019 · No Comments